Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03432286
Brief Title: A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

First Submitted : February 8, 2018
First Submitted that Met QC Criteria : February 8, 2018
First Posted : February 14, 2018

Last Update Submitted that Met QC Criteria : May 4, 2021
Last Update Posted : May 5, 2021